Capital expenditures incurred but not yet paid
Medline, Inc. Capital expenditures incurred but not yet paid remained flat by 0.0% to $14.5M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 16.0%, from $12.5M to $14.5M. Over 2 years (FY 2023 to FY 2025), Capital expenditures incurred but not yet paid shows an upward trend with a 52.3% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Analysis
How to read this metric
A high balance suggests a lag between investment commitment and cash payment, which can temporarily inflate operating cash flow.
Detailed definition
Capital expenditures that have been incurred and recognized as assets but have not yet resulted in a cash outflow. This...
Peer comparison
Often found in the supplemental non-cash investing activities section of the cash flow statement.
amd_capex_unpaidHistorical Data
| FY'23 | FY'24 | FY'25 | |
|---|---|---|---|
| Value | $25M | $50M | $58M |
| YoY Change | — | +100.0% | +16.0% |
Capital expenditures incurred but not yet paid at Other Companies
Frequently Asked Questions
- What is Medline, Inc. 's capital expenditures incurred but not yet paid?
- Medline, Inc. (MDLN) reported capital expenditures incurred but not yet paid of $14.5M in Q4 2025.
- How has Medline, Inc. 's capital expenditures incurred but not yet paid changed year-over-year?
- Medline, Inc. 's capital expenditures incurred but not yet paid increased by 16.0% year-over-year, from $12.5M to $14.5M.
- What is the long-term trend for Medline, Inc. 's capital expenditures incurred but not yet paid?
- Over 2 years (2023 to 2025), Medline, Inc. 's capital expenditures incurred but not yet paid has grown at a 52.3% compound annual growth rate (CAGR), from $25M to $58M.
- What does capital expenditures incurred but not yet paid mean?
- Capital investments made during the period that have not yet been paid for in cash.